Skip to main content
SpringerLink
Log in

Live-Attenuated and Inactivated Whole-Cell Bacterial Vaccines

  • Chapter
  • First Online:
Vaccine Analysis: Strategies, Principles, and Control

  • 3388 Accesses

Abstract

Pathogen attenuation to allow its safe administration to protect otherwise susceptible subjects from infection is one of the earliest principles of vaccinology. At the same time that the first live-attenuated vaccines were developed, immunization with killed bacteria was being explored. Thus, live-attenuated and inactivated whole-cell bacterial vaccines are the oldest human vaccines still in use today. Live-attenuated bacterial vaccines currently in use are Bacille Calmette-Guérin (BCG) vaccines that have demonstrated effectiveness in preventing disseminated childhood tuberculosis and that are still used to immunize newborns worldwide; and a typhoid vaccine that is used primarily as a traveler’s vaccine. Killed whole-cell bacterial vaccines still in use are Bordetella pertussis vaccines which continue to be administered to prevent whooping cough to the majority of the global birth cohort, particularly in low-income countries; and cholera vaccines which are used mainly by travelers to endemic areas, and to a lesser extent to control infections in endemic or epidemic settings. The production of live-attenuated and killed vaccines has been troubled historically by issues of quality and poor efficacy. Incomplete attenuation is associated with the risk of acute infection and disease by the vaccine strain. Production of inactivated vaccines of inconsistent potency and quality has led to outbreaks of disease in countries where vaccines of low potency have been used. Serological correlates of protection have not been identified. New approaches to prevent these bacterial diseases, including the development of live genetically attenuated vaccines are under development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aaby P, Benn CS (2012) Saving lives by training innate immunity with bacille Calmette-Guerin vaccine. Proc Natl Acad Sci USA 109(43):17317–17318. doi:10.1073/pnas.1215761109

    CAS  PubMed Central  PubMed  Google Scholar 

  • Alam M, Sultana M, Nair GB, Siddique AK, Hasan NA, Sack RB, Sack DA, Ahmed KU, Sadique A, Watanabe H, Grim CJ, Huq A, Colwell RR (2007) Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci USA 104(45):17801–17806. doi:10.1073/pnas.0705599104

    CAS  PubMed Central  PubMed  Google Scholar 

  • Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA (2012) Outbreak of bacille Calmette-Guerin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med 32(1):4–8

    PubMed  Google Scholar 

  • Aporta A, Arbues A, Aguilo JI, Monzon M, Badiola JJ, de Martino A, Ferrer N, Marinova D, Anel A, Martin C, Pardo J (2012) Attenuated Mycobacterium tuberculosis SO2 vaccine candidate is unable to induce cell death. PLoS ONE 7(9):e45213. doi:10.1371/journal.pone.0045213

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A (1997) Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 65(6):2168–2174

    CAS  PubMed Central  PubMed  Google Scholar 

  • Benitez JA, Garcia L, Silva A, Garcia H, Fando R, Cedre B, Perez A, Campos J, Rodriguez BL, Perez JL, Valmaseda T, Perez O, Ramirez M, Ledon T, Jidy MD, Lastre M, Bravo L, Sierra G (1999) Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun 67(2):539–545

    CAS  PubMed Central  PubMed  Google Scholar 

  • Black RE, Levine MM, Clements ML, Losonsky GA, Herrington D, Berman S, Formal SB (1987) Prevention of shigellosis by a Salmonella typhi–Shigella sonnei bivalent vaccine. J Infect Dis 155(6):1260–1265

    Google Scholar 

  • Bordet J, Gengou U (1906) Le microbe de la coqueluche. Ann Inst Pasteur 20:48–68

    Google Scholar 

  • Burgess M, Forrest J (1996) Pertussis and the acellular vaccines. Commun Dis Intell 20:192–193

    Google Scholar 

  • Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, Whittle H, McShane H, Rowland-Jones SL, Flanagan KL (2010) Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 185(4):2620–2628. doi:10.4049/jimmunol.1000552

    CAS  PubMed  Google Scholar 

  • Calain P, Chaine JP, Johnson E, Hawley ML, O’Leary MJ, Oshitani H, Chaignat CL (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22(19):2444–2451

    CAS  PubMed  Google Scholar 

  • Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, Miller E (2012) Accelerating control of pertussis in England and Wales. Emerg Infect Dis 18(1):38–47. doi:10.3201/eid1801.110784

    PubMed Central  PubMed  Google Scholar 

  • Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH (2001) CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167(5):2734–2742

    CAS  PubMed  Google Scholar 

  • Capinos Scherer CF, Endsley JJ, de Aguiar JB, Jacobs WR Jr, Larsen MH, Palmer MV, Nonnecke BJ, Ray Waters W, Mark Estes D (2009) Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovisDeltaRD1. Transbound Emerg Dis 56(6–7):228–239. doi:10.1111/j.1865-1682.2008.01058.x

  • Cardona PJ, Asensio JG, Arbues A, Otal I, Lafoz C, Gil O, Caceres N, Ausina V, Gicquel B, Martin C (2009) Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant. Vaccine 27(18):2499–2505. doi:10.1016/j.vaccine.2009.02.060

    CAS  PubMed  Google Scholar 

  • Centers for Disease Control and Prevention (2002) Pertussis–United States, 1997–2000. MMWR Morb Mortal Wkly Rep 51(4):73–76

    Google Scholar 

  • Chackerian AA, Perera TV, Behar SM (2001) Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 69(4):2666–2674. doi:10.1128/IAI.69.4.2666-2674.2001

    CAS  PubMed Central  PubMed  Google Scholar 

  • Charles RC, Harris JB, Chase MR, Lebrun LM, Sheikh A, Larocque RC, Logvinenko T, Rollins SM, Tarique A, Hohmann EL, Rosenberg I, Krastins B, Sarracino DA, Qadri F, Calderwood SB, Ryan ET (2009) Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS ONE 4(9):e6994

    Google Scholar 

  • Cherry JD (1996) Historical review of pertussis and the classical vaccine. J Infect Dis 174(Suppl 3):S259–S263

    PubMed  Google Scholar 

  • Chowdhury MI, Sheikh A, Qadri F (2009) Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991–2009. Expert Rev Vaccines 8(12):1643–1652

    CAS  PubMed  Google Scholar 

  • Clemens J, Shin S, Sur D, Nair GB, Holmgren J (2011) New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol 8(12):701–710

    CAS  PubMed  Google Scholar 

  • Clemens JD, Harris JR, Sack DA, Chakraborty J, Ahmed F, Stanton BF, Khan MU, Kay BA, Huda N, Khan MR et al (1988) Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis 158(1):60–69

    CAS  PubMed  Google Scholar 

  • Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N et al (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335(8684):270–273

    CAS  PubMed  Google Scholar 

  • Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178(6):2243–2247

    CAS  PubMed  Google Scholar 

  • Corbel MJ (1996) Reasons for instability of bacterial vaccines. Dev Biol Stand 87:113–124

    CAS  PubMed  Google Scholar 

  • Corbel MJ, Kreeftenberg JG, Knezevic I (2004) WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6–7 May 2003, Ferney Voltaire, France. Vaccine 22(3–4):293–300

    CAS  PubMed  Google Scholar 

  • Corbel MJ, Xing DK (2004) Toxicity and potency evaluation of pertussis vaccines. Expert Rev Vaccines 3(1):89–101. doi:10.1586/14760584.3.4.S89

    CAS  PubMed  Google Scholar 

  • Cornford-Nairns R, Daggard G, Mukkur T (2012) Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate. J Microbiol Biotechnol 22(6):856–865

    CAS  PubMed  Google Scholar 

  • Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS (2008) Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 121(3):484–492. doi:10.1542/peds.2007-1393

    PubMed  Google Scholar 

  • Coster TS, Killeen KP, Waldor MK, Beattie DT, Spriggs DR, Kenner JR, Trofa A, Sadoff JC, Mekalanos JJ, Taylor DN (1995) Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345(8955):949–952

    CAS  PubMed  Google Scholar 

  • Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, Heath P, Murdoch I, Zambon M, George R, Miller E (2003) Severe and unrecognised: pertussis in UK infants. Arch Dis Child 88(9):802–806

    CAS  PubMed Central  PubMed  Google Scholar 

  • Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82(5):346–353

    PubMed Central  PubMed  Google Scholar 

  • Davisson EO, Powell HM, Macfarlane JO, Hodgson R, Stone RL, Culbertson CG (1956) The preservation of poliomyelitis vaccine with stabilized merthiolate. J Lab Clin Med 47(1):8–19

    CAS  PubMed  Google Scholar 

  • de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M (2012) Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology 23(6):852–860. doi:10.1097/EDE.0b013e31826c2b9e

    PubMed  Google Scholar 

  • de Melker HE, Conyn-van Spaendonck MA, Rumke HC, van Wijngaarden JK, Mooi FR, Schellekens JF (1997) Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 3(2):175–178. doi:10.3201/eid0302.970211

    PubMed Central  PubMed  Google Scholar 

  • De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville Fradet M, Rochette L, Halperin SA (2000) Morbidity of pertussis in adolescents and adults. J Infect Dis 182(1):174–179. doi:10.1086/315648

    PubMed  Google Scholar 

  • Denoel P, Godfroid F, Guiso N, Hallander H, Poolman J (2005) Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 23(46–47):5333–5341. doi:10.1016/j.vaccine.2005.06.021

    CAS  PubMed  Google Scholar 

  • Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D (2011) Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37(1):88–99. doi:10.1183/09031936.00115110

    CAS  PubMed  Google Scholar 

  • Donoghue HD, Lee OY, Minnikin DE, Besra GS, Taylor JH, Spigelman M (2010) Tuberculosis in Dr Granville’s mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis. Proc Biol Sci 277(1678):51–56. doi:10.1098/rspb.2009.1484

    CAS  PubMed Central  PubMed  Google Scholar 

  • Edwards KM (2005) Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 24(6 Suppl):S104–S108

    PubMed  Google Scholar 

  • Edwards KM, Decker MD, Halsey NA, Koblin BA, Townsend T, Auerbach B, Karzon DT (1991) Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 88(5):1019–1023

    CAS  PubMed  Google Scholar 

  • Ernst WA, Thoma-Uszynski S, Teitelbaum R, Ko C, Hanson DA, Clayberger C, Krensky AM, Leippe M, Bloom BR, Ganz T, Modlin RL (2000) Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol 165(12):7102–7108

    CAS  PubMed  Google Scholar 

  • Favre D, Struck MM, Cryz SJ Jr, Viret JF (1996) Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR. Vaccine 14(6):526–531

    CAS  PubMed  Google Scholar 

  • Feunou PF, Bertout J, Locht C (2010a) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS ONE 5(4):e10178 doi:10.1371/journal.pone.0010178

  • Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C (2010b) Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine 28(43):7047–7053. doi:10.1016/j.vaccine.2010.08.017

  • Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346(8986):1339–1345

    CAS  PubMed  Google Scholar 

  • Fine PE, Clarkson JA (1987) Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 9(5):866–883

    CAS  PubMed  Google Scholar 

  • Fine PE, Ponnighaus JM, Maine NP (1986) The relationship between delayed type hypersensitivity and protective immunity induced by mycobacterial vaccines in man. Lepr Rev 57(Suppl 2):275–283

    PubMed  Google Scholar 

  • Fine PE, Sterne JA, Ponnighaus JM, Rees RJ (1994) Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344(8932):1245–1249

    CAS  PubMed  Google Scholar 

  • Fleming PJ, Blair PS, Platt MW, Tripp J, Smith IJ, Golding J (2001) The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study. BMJ 322(7290):822

    CAS  PubMed Central  PubMed  Google Scholar 

  • Formal SB, Baron LS, Kopecko DJ, Washington O, Powell C, Life CA (1981) Construction of a potential bivalent vaccine strain: introduction of Shigella sonnet form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 34(3):746–750

    CAS  PubMed Central  PubMed  Google Scholar 

  • Galazka A (1993) Pertussis. In The immunological basis for immunization. WHO/EPI/GEN/93.14:1–20

    Google Scholar 

  • Gale JL, Thapa PB, Wassilak SG, Bobo JK, Mendelman PM, Foy HM (1994) Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA 271(1):37–41

    CAS  PubMed  Google Scholar 

  • Garcia HM, Thompson R, Valera R, Fando R, Fumane J, Jani I, Mirabal M, Armesto MI, Songane M, Luis S, Nzualo AM, Celeste J, Viegas S, Gudo ES, Melembe A, Bila D, Cema C, Mabumo C, Garcia L, Cedre B, Ano G, Martinez JC, Mandarioti A, Lugones J, Gonzalez D, Baro M, Hernandez J, Talavera A, Solis RL, Sierra G, Barbera R, Dominguez F, Gutierrez C, Campa C, Garrido I, Menendez J (2011) A single dose of live-attenuated 638 Vibrio cholerae oral vaccine is safe and immunogenic in adult volunteers in Mozambique. VacciMonitor 20(3):1–8

    Google Scholar 

  • Garcia L, Jidy MD, Garcia H, Rodriguez BL, Fernandez R, Ano G, Cedre B, Valmaseda T, Suzarte E, Ramirez M, Pino Y, Campos J, Menendez J, Valera R, Gonzalez D, Gonzalez I, Perez O, Serrano T, Lastre M, Miralles F, Del Campo J, Maestre JL, Perez JL, Talavera A, Perez A, Marrero K, Ledon T, Fando R (2005) The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect Immun 73(5):3018–3024

    CAS  PubMed Central  PubMed  Google Scholar 

  • Garmory HS, Brown KA, Titball RW (2002) Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 26(4):339–353

    CAS  PubMed  Google Scholar 

  • Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334(6):341–348. doi:10.1056/NEJM199602083340601

  • Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W (1990) Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA 263(12):1641–1645

    CAS  PubMed  Google Scholar 

  • Grimprel E, Begue P, Anjak I, Njamkepo E, Francois P, Guiso N (1996) Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol 3(1):93–97

    CAS  PubMed Central  PubMed  Google Scholar 

  • Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, van Soolingen D, Raupach B, Kaufmann SH (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115(9):2472–2479. doi:10.1172/JCI24617

    CAS  PubMed Central  PubMed  Google Scholar 

  • Guiso N, Capiau C, Carletti G, Poolman J, Hauser P (1999) Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17(19):2366–2376

    CAS  PubMed  Google Scholar 

  • Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334(6):349–355. doi:10.1056/NEJM199602083340602

    CAS  PubMed  Google Scholar 

  • Hallander H, Nilsson L, Gustafsson L (2011) Is adolescent pertussis vaccination preferable to natural booster infections? Expert reviews of clinical pharmacology

    Google Scholar 

  • Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB (2012) Cholera. Lancet 379(9835):2466–2476. doi:10.1016/S0140-6736(12)60436-X

    PubMed Central  PubMed  Google Scholar 

  • Health Council of the Netherlands (2004) Vaccination against pertussis (Vaccinatie tegen kinkhoest). The Hague

    Google Scholar 

  • Heininger U (2010) Update on pertussis in children. Expert Rev Anti Infect Ther 8(2):163–173

    PubMed  Google Scholar 

  • Hindle Z, Chatfield SN, Phillimore J, Bentley ML, Johnson J (2002) Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Vaccine 24:116–123

    Google Scholar 

  • Ho SY, Chua SQ, Foo DG, Locht C, Chow VT, Poh CL, Alonso S (2008) Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates. Infect Immun 76(1):111–119. doi:10.1128/IAI.00795-07

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hoffman HJ, Hunter JC, Damus K, Pakter J, Peterson DR, van Belle G, Hasselmeyer EG (1987) Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors. Pediatrics 79(4):598–611

    CAS  PubMed  Google Scholar 

  • Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198(10):1491–1501. doi:10.1086/592450

    PubMed Central  PubMed  Google Scholar 

  • Hohmann EL, Oletta CA, Killeen KP, Miller SI (1996) phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 173(6):1408–1414

    CAS  PubMed  Google Scholar 

  • Howson CP, Fineberg HV (1992) Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 267(3):392–396

    CAS  PubMed  Google Scholar 

  • iDrugInfo.com (2000–2012) Pentacoq. In: Drugs information. http://www.idruginfo.com/drugs-p/pen/pentacoq.html

  • Jain SK (2009) M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever. Curr Opin Mol Ther 11(5):565–571

    CAS  PubMed  Google Scholar 

  • Jefferson T, Rudin M, DiPietrantonj C (2003) Systematic review of the effects of pertussis vaccines in children. Vaccine 21(17–18):2003–2014

    CAS  PubMed  Google Scholar 

  • Kammoun H, Feunou PF, Foligne B, Debrie AS, Raze D, Mielcarek N, Locht C (2012) Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Vaccine 30(40):5864–5870. doi:10.1016/j.vaccine.2012.07.005

    CAS  PubMed  Google Scholar 

  • Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JW, van Crevel R, Netea MG (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 109(43):17537–17542. doi:10.1073/pnas.1202870109

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kopecko DJ, Sieber H, Ures JA, Furer A, Schlup J, Knof U, Collioud A, Xu D, Colburn K, Dietrich G (2009) Genetic stability of vaccine strain Salmonella typhi Ty21a over 25 years. Int J Med Microbiol 299(4):233–246

    CAS  PubMed  Google Scholar 

  • Kupferschmidt K (2011) Infectious disease. Taking a new shot at a TB vaccine. Science 334(6062):1488–1490. doi:10.1126/science.334.6062.1488

  • Lacombe K, Yam A, Simondon K, Pinchinat S, Simondon F (2004) Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children. Vaccine 23(5):623–628. doi:10.1016/j.vaccine.2004.07.007

    CAS  PubMed  Google Scholar 

  • Lagos R, San Martin O, Wasserman SS, Prado V, Losonsky GA, Bustamante C, Levine MM (1999) Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers. Pediatr Infect Dis J 18(7):624–630

    CAS  PubMed  Google Scholar 

  • Larsen MH, Biermann K, Chen B, Hsu T, Sambandamurthy VK, Lackner AA, Aye PP, Didier P, Huang D, Shao L, Wei H, Letvin NL, Frothingham R, Haynes BF, Chen ZW, Jacobs WR Jr (2009) Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine 27(34):4709–4717. doi:10.1016/j.vaccine.2009.05.050

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lee GM, Lett S, Schauer S, LeBaron C, Murphy TV, Rusinak D, Lieu TA, Massachusetts Pertussis Study G (2004) Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 39(11):1572–1580. doi:10.1086/425006

  • Lee WI, Huang JL, Yeh KW, Jaing TH, Lin TY, Huang YC, Chiu CH (2011) Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). J Formos Med Assoc 110(12):750–758. doi:10.1016/j.jfma.2011.11.004

    CAS  PubMed  Google Scholar 

  • Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S (1999) Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17(Suppl 2):S22–S27

    PubMed  Google Scholar 

  • Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC (2007) Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis 45(Suppl 1):S24–S28

    CAS  PubMed  Google Scholar 

  • Levine MM, Kaper JB, Herrington D, Ketley J, Losonsky G, Tacket CO, Tall B, Cryz S (1988) Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 2(8609):467–470

    CAS  PubMed  Google Scholar 

  • Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM (2007) Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J 29(6):1212–1216. doi:10.1183/09031936.00117506

    CAS  PubMed  Google Scholar 

  • Liko J, Robinson SG, Cieslak PR (2013) Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 368(6):581–582

    Google Scholar 

  • Lin FY, Vo AH, Phan VB, Nguyen TT, Bryla D, Tran CT, Ha BK, Dang DT, Robbins JB (2000) The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 62(5):644–648

    CAS  PubMed  Google Scholar 

  • Liu D, Verma NK, Romana LK, Reeves PR (1991) Relationships among the rfb regions of Salmonella serovars A, B, and D. J Bacteriol 173:4814–4819

    CAS  Google Scholar 

  • Locht C, Antoine R, Raze D, Mielcarek N, Hot D, Lemoine Y, Mascart F (2004) Bordetella pertussis from functional genomics to intranasal vaccination. Int J Med Microbiol 293(7–8):583–588

    CAS  PubMed  Google Scholar 

  • Locht C, Mielcarek N (2012) New pertussis vaccination approaches: en route to protect newborns? FEMS Immunol Med Microbiol 66(2):121–133. doi:10.1111/j.1574-695X.2012.00988.x

    CAS  PubMed  Google Scholar 

  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128

    PubMed  Google Scholar 

  • Lugauer S, Heininger U, Cherry JD, Stehr K (2002) Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr 161(3):142–146

    CAS  PubMed  Google Scholar 

  • Mahon BP, Brady MT, Mills KH (2000) Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis 181(6):2087–2091. doi:10.1086/315527

    CAS  PubMed  Google Scholar 

  • Marchant A, Goldman M (2005) T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 141(1):10–18. doi:10.1111/j.1365-2249.2005.02799.x

    CAS  PubMed Central  PubMed  Google Scholar 

  • Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, Bordat Y, Soto CY, Clark SO, Hatch GJ, Aguilar D, Ausina V, Gicquel B (2006) The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24(17):3408–3419. doi:10.1016/j.vaccine.2006.03.017

    CAS  PubMed  Google Scholar 

  • Mielcarek N, Debrie AS, Mahieux S, Locht C (2010) Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol 17(3):317–324. doi:10.1128/CVI.00322-09

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C (2006a) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2(7):e65. doi:10.1371/journal.ppat.0020065

  • Mielcarek N, Debrie AS, Raze D, Quatannens J, Engle J, Goldman WE, Locht C (2006b) Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Vaccine 24(Suppl 2):S2-54–55

    Google Scholar 

  • Miller D, Madge N, Diamond J, Wadsworth J, Ross E (1993) Pertussis immunisation and serious acute neurological illnesses in children. BMJ 307(6913):1171–1176

    CAS  PubMed Central  PubMed  Google Scholar 

  • Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NS (1981) Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 282(6276):1595–1599

    CAS  Google Scholar 

  • Milstien JB, Gibson JJ (1990) Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Org 68(1):93–108

    CAS  PubMed Central  PubMed  Google Scholar 

  • Moore DL, Le Saux N, Scheifele D, Halperin SA (2004) Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993–2002. Pediatr Infect Dis J 23(6):568–571

    PubMed  Google Scholar 

  • Mueller H, Fae KC, Magdorf K, Ganoza CA, Wahn U, Guhlich U, Feiterna-Sperling C, Kaufmann SH (2011) Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS ONE 6(12):e29367. doi:10.1371/journal.pone.0029367

    CAS  PubMed Central  PubMed  Google Scholar 

  • Nair GB, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, Sack DA (2002) New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol 40(9):3296–3299

    PubMed Central  PubMed  Google Scholar 

  • Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656

    CAS  Google Scholar 

  • Ohtake S, Martin R, Saxena A, Pham B, Chiueh G, Osorio M, Kopecko D, Xu D, Lechuga-Ballesteros D, Truong-Le V (2011) Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines. Vaccine 29(15):2761–2771

    Google Scholar 

  • Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, Bogaerts H, Storsaeter J (2003) Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 21(17–18):2015–2021

    PubMed  Google Scholar 

  • Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharya SK, Blake MS, Kopecko OJ (2009) Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge. Infect Immun 77(4):1475–1482

    Google Scholar 

  • Ottenhoff TH, Kaufmann SH (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8(5):e1002607. doi:10.1371/journal.ppat.1002607

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pakkanen SH, Kantele JM, Kantele A (2012) Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine 30(42):6047–6053

    CAS  PubMed  Google Scholar 

  • Pasetti MF, Simon JK, Sztein MB, Levine MM (2011) Immunology of gut mucosal vaccines. Immunol Rev 239(1):125–148

    CAS  PubMed Central  PubMed  Google Scholar 

  • Paz S, Broza M (2007) WInd direction and its linkage with Vibrio cholerae dissemination. Environ Health Perspect 115:195–200

    Google Scholar 

  • Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, Martin C (2001) An essential role for phoP in Mycobacterium tuberculosis virulence. Mol Microbiol 41(1):179–187

    CAS  PubMed  Google Scholar 

  • Pichichero ME, Treanor J (1997) Economic impact of pertussis. Arch Pediatr Adolesc Med 151(1):35–40

    CAS  PubMed  Google Scholar 

  • Pittman M (1991) History of the development of pertussis vaccine. Dev Biol Stand 73:13–29

    CAS  PubMed  Google Scholar 

  • Pollard R (1980) Relation between vaccination and notification rates for whooping cough in England and Wales. Lancet 1(8179):1180–1182

    CAS  PubMed  Google Scholar 

  • Poolman JT, Hallander H, Halperin SA (2011) Pertussis vaccines: where to now? Expert Rev Vaccines 10(11):1497–1500. doi:10.1586/erv.11.147

    PubMed  Google Scholar 

  • Pulickal AS, Gautam S, Clutterbuck EA, Thorson S, Basynat B, Adhikari N, Makepeace K, Rijpkema S, Borrow R, Farrar JJ, Pollard AJ (2009) Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal. Clin Vaccine Immunol 16(10):1413–1419

    CAS  PubMed Central  PubMed  Google Scholar 

  • Qualls JE, Neale G, Smith AM, Koo MS, DeFreitas AA, Zhang H, Kaplan G, Watowich SS, Murray PJ (2010) Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci Signal 3(135):ra62. doi:10.1126/scisignal.2000955

  • Quiambao B, Van Der Meeren O, Kolhe D, Gatchalian S (2012) A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers. Hum Vaccin Immunother 8(3):347–354. doi:10.4161/hv.18630

  • Richie EE, Punjabi NH, Sidharta YY, Peetosutan KK, Sukandar MM, Wasserman SS, Lesmana MM, Wangsasaputra FF, Pandam SS, Levine MM, O’Hanley PP, Cryz SJ, Simanjuntak CH (2000) Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18(22):2399–2410

    CAS  PubMed  Google Scholar 

  • Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N (2008) Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 32(5):821–841. doi:10.1111/j.1574-6976.2008.00118.x

    CAS  PubMed  Google Scholar 

  • Rivera IN, Souza KM, Souza CP, Lopes RM (2012) Free-living and plankton-associated Vibrios: assessment in ballast water, harbor areas, and coastal ecosystems in Brazil. Front Microbiol 3:443

    PubMed Central  PubMed  Google Scholar 

  • Robbins G, Tripathy VM, Misra VN, Mohanty RK, Shinde VS, Gray KM, Schug MD (2009) Ancient skeletal evidence for leprosy in India (2000 B.C.). PLoS ONE 4(5):e5669. doi:10.1371/journal.pone.0005669

    PubMed Central  PubMed  Google Scholar 

  • Roland KL, Cloninger C, Kochi SK, Thomas LJ, Tinge SA, Rouskey C, Killeen KP (2007) Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. Vaccine 25(51):8574–8584

    CAS  PubMed  Google Scholar 

  • Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, Jensen H, Sodemann M, Rodriques A, Aaby P (2005) BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol 34(3):540–547. doi:10.1093/ije/dyh392

    PubMed  Google Scholar 

  • Roth AE, Stensballe LG, Garly ML, Aaby P (2006) Beneficial non-targeted effects of BCG–ethical implications for the coming introduction of new TB vaccines. Tuberculosis (Edinb) 86(6):397–403. doi:10.1016/j.tube.2006.02.001

    CAS  Google Scholar 

  • Rumke HC, Schlumberger M, Floury B, Nagel J, van Steenis B (1993) Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso. Vaccine 11(11):1113–1118

    CAS  PubMed  Google Scholar 

  • Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Oymar K, Miller E, Storsaeter J, Mills KH (1998) Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93(1):1–10

    CAS  PubMed Central  PubMed  Google Scholar 

  • Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage IIIWG (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 108(5):E81

    Google Scholar 

  • Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR Jr (2006) Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24(37–39):6309–6320. doi:10.1016/j.vaccine.2006.05.097

    CAS  PubMed  Google Scholar 

  • Sambandamurthy VK, Derrick SC, Jalapathy KV, Chen B, Russell RG, Morris SL, Jacobs WR Jr (2005) Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect Immun 73(2):1196–1203. doi:10.1128/IAI.73.2.1196-1203.2005

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sanchez J, Holmgren J (1989) Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 86(2):481–485

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sato H, Sato Y (1999a) Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. Clin Infect Dis 28(Suppl 2):S124–S130. doi:10.1086/515063

    PubMed  Google Scholar 

  • Sato Y, Sato H (1999b) Development of acellular pertussis vaccines. Biologicals 27(2):61–69. doi:10.1006/biol.1999.0181

    CAS  PubMed  Google Scholar 

  • Sawyer LA, McInnis J, Patel A, Horne AD, Albrecht P (1994) Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine. Vaccine 12(9):851–856

    CAS  PubMed  Google Scholar 

  • Schluger NW (2001) Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2(3):157–163

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37(1):100–111. doi:10.1183/09031936.00114810

    CAS  PubMed  Google Scholar 

  • Sheridan SL, Ware RS, Grimwood K, Lambert SB (2012) Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308(5):454–456. doi:10.1001/jama.2012.6364

    CAS  PubMed  Google Scholar 

  • Silva Miranda M, Breiman A, Allain S, Deknuydt F, Altare F (2012) The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev Immunol 2012:139127. doi:10.1155/2012/139127

    PubMed Central  PubMed  Google Scholar 

  • Simanjuntak CH, O’Hanley P, Punjabi NH, Noriega F, Pazzaglia G, Dykstra P, Kay B, Suharyono, Budiarso A, Rifai AR, et al. (1993) Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children. J Infect Dis 168(5):1169–1176

    Google Scholar 

  • Simon R, Tennant SM, Galen JE, Levine MM (2011) Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. Vaccine 29(32):5094–5106

    CAS  PubMed Central  PubMed  Google Scholar 

  • Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP (2009) A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol 16(9):1344–1351. doi:10.1128/CVI.00082-09

    CAS  PubMed Central  PubMed  Google Scholar 

  • Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, Champagne S, Patrick DM, Halperin SA (2002) The changing age and seasonal profile of pertussis in Canada. J Infect Dis 185(10):1448–1453. doi:10.1086/340280

    PubMed  Google Scholar 

  • Steinhoff MC, Reed GF, Decker MD, Edwards KM, Englund JA, Pichichero ME, Rennels MB, Anderson EL, Deloria MA, Meade BD (1995) A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines. Pediatrics 96(3 Pt 2):567–570

    CAS  PubMed  Google Scholar 

  • Stojanov S, Liese J, Belohradsky BH (2000) Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection 28(2):106–110

    CAS  PubMed  Google Scholar 

  • Storsaeter J, Wolter J (2006) Is there a need for a new generation of vaccines against pertussis? Expert Opin Emerg Drugs 11(2):195–205. doi:10.1517/14728214.11.2.195

    CAS  PubMed  Google Scholar 

  • Storsaeter J, Wolter J, Locht C (2007) Pertussis vaccines. In: Locht C (ed) Bordetella molecular microbiology. Horizon Bioscience, UK

    Google Scholar 

  • Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC (2009) Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 27(33):4412–4423. doi:10.1016/j.vaccine.2009.05.048

    CAS  PubMed  Google Scholar 

  • Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL (2011) Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5(10):e1289

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sutherland I, Lindgren I (1979) The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle 60(4):225–231

    CAS  PubMed  Google Scholar 

  • Svennerholm AM (2011) From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 133:188–196

    CAS  PubMed Central  PubMed  Google Scholar 

  • Svennerholm AM, Holmgren J (1976) Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun 13(3):735–740

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sweeney KA, Dao DN, Goldberg MF, Hsu T, Venkataswamy MM, Henao-Tamayo M, Ordway D, Sellers RS, Jain P, Chen B, Chen M, Kim J, Lukose R, Chan J, Orme IM, Porcelli SA, Jacobs WR Jr (2011) A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med 17(10):1261–1268. doi:10.1038/nm.2420

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tacket CO, Cohen MB, Wasserman SS, Losonsky G, Livio S, Kotloff K, Edelman R, Kaper JB, Cryz SJ, Giannella RA, Schiff G, Levine MM (1999) Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect Immun 67(12):6341–6345

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tacket CO, Levine MM (2007) CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin Infect Dis 45(Suppl 1):S20–S23

    CAS  PubMed  Google Scholar 

  • Tennant SM, Wang JY, Galen JE, Simon R, Pasetti MF, Gat O, Levine MM (2011) Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains. Infect Immun 79(10):4175–4185

    CAS  PubMed Central  PubMed  Google Scholar 

  • Therre H, Baron S (2000) Pertussis immunisation in Europe—the situation in late 1999. Euro Surveill 5(1):6–10

    PubMed  Google Scholar 

  • Tomovasu T, Ohkishi T, Ukyo Y, Tokumitsu A, Takaya A, Suzuki M, Sekiya K, Matsui H, Kutsukake K, Yomamoto T (2002) The ClpX ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar Typhimurium. J Bacteriol 184(3):645–653

    Google Scholar 

  • Tran TH, Nguyen TD, Nguyen TT, Ninh TT, Tran NB, Nguyen VM, Tran TT, Cao TT, Pham VM, Nguyen TC, Tran TD, Pham VT, To SD, Campbell JI, Stockwell E, Schultsz C, Simmons CP, Glover C, Lam W, Marques F, May JP, Upton A, Budhram R, Dougan G, Farrar J, Nguyen VV, Dolecek C (2010) A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children. PLoS ONE 5(7):e11778

    PubMed  Google Scholar 

  • Trunz BB, Fine P, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367(9517):1173–1180. doi:10.1016/S0140-6736(06)68507-3

    PubMed  Google Scholar 

  • Vekemans J, Amedei A, Ota MO, D’Elios MM, Goetghebuer T, Ismaili J, Newport MJ, Del Prete G, Goldman M, McAdam KP, Marchant A (2001) Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 31(5):1531–1535. doi:10.1002/1521-4141(200105)31:5<1531:AID-IMMU1531>3.0.CO;2-1

    CAS  PubMed  Google Scholar 

  • Venkataswamy MM, Goldberg MF, Baena A, Chan J, Jacobs WR Jr, Porcelli SA (2012) In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG. Vaccine 30(6):1038–1049. doi:10.1016/j.vaccine.2011.12.044

    CAS  PubMed Central  PubMed  Google Scholar 

  • Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, van der Werff NM, Kersbergen A, Ottenhoff TH, Heidt PJ, Gilbert SC, Gicquel B, Hill AV, Martin C, McShane H, Thomas AW (2009) MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS ONE 4(4):e5264. doi:10.1371/journal.pone.0005264

    PubMed Central  PubMed  Google Scholar 

  • Vogel FR, Leclerc C, Schutze MP, Jolivet M, Audibert F, Klein TW, Chedid L (1987) Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide. Cell Immunol 107(1):40–51

    CAS  PubMed  Google Scholar 

  • von Konig CH, Halperin S, Riffelmann M, Guiso N (2002) Pertussis of adults and infants. Lancet Infect Dis 2(12):744–750

    Google Scholar 

  • von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K, DarDar Study G (2010) Prevention of tuberculosis in bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS 24(5):675–685. doi:10.1097/QAD.0b013e3283350f1b

  • Wahid R, Pasetti MF, Maciel M Jr, Simon JK, Tacket CO, Levine MM, Sztein MB (2011) Oral priming with Salmonella typhi vaccine strain CVD 909 followed by parenteral boost with the S. typhi Vi capsular polysaccharide vaccine induces CD27+ IgD-S. typhi-specific IgA and IgG B memory cells in humans. Clin Immunol 138(2):187–200

    Google Scholar 

  • Wahid R, Simon R, Zafar SJ, Levine MM, Sztein MB (2012) Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. paratyphi B in humans. Clin Vaccine Immunol 19(6):825–834

    CAS  PubMed Central  PubMed  Google Scholar 

  • Walker AM, Jick H, Perera DR, Knauss TA, Thompson RS (1988) Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics 81(3):345–349

    CAS  PubMed  Google Scholar 

  • Walker V, Selby G, Wacogne I (2006) Does neonatal BCG vaccination protect against tuberculous meningitis? Arch Dis Child 91(9):789–791. doi:10.1136/adc.2006.098459

    CAS  PubMed Central  PubMed  Google Scholar 

  • Wang JY, Pasetti MF, Noriega FR, Anderson RJ, S.S. W, Galen JE, Sztein MB, Levine MM (2001) Construction, genotypic and phenotypic characterization, and immunogenciity of attenated DeltaguaBA Salmonella enterica serover Typhi strain CVD 915. Infect Immun 69(8):4734–4741

    Google Scholar 

  • Watkins ML, Semple PL, Abel B, Hanekom WA, Kaplan G, Ress SR (2008) Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol 15(11):1666–1673. doi:10.1128/CVI.00202-08

    CAS  PubMed Central  PubMed  Google Scholar 

  • Weingart CL, Keitel WA, Edwards KM, Weiss AA (2000) Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun 68(12):7175–7179

    CAS  PubMed Central  PubMed  Google Scholar 

  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24(5 Suppl):S58–S61

    PubMed  Google Scholar 

  • Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G (2012) California pertussis epidemic, 2010. J Pediatr. doi:10.1016/j.jpeds.2012.05.041

    PubMed  Google Scholar 

  • Witt MA, Katz PH, Witt DJ (2012) Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 54(12):1730–1735. doi:10.1093/cid/cis287

    CAS  PubMed  Google Scholar 

  • Woodworth JS, Wu Y, Behar SM (2008) Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol 181(12):8595–8603

    CAS  PubMed Central  PubMed  Google Scholar 

  • World Health Organization (2001) Cholera vaccines. WHO position paper. WHO Wkly Epidemiol Rec 76(16):117–124

    Google Scholar 

  • World Health Organization (2004) BCG vaccine. WHO position paper. Wkly Epidemiol Rec 79(4):27–38

    Google Scholar 

  • World Health Organization (2005) Pertussis vaccines–WHO position paper. Wkly Epidemiol Rec 80(4):31–39

    Google Scholar 

  • World Health Organization (2010) Global Advisory Committee on vaccine safety, 3–4 December 2009. Wkly Epidemiol Rec 85(5):29–33

    Google Scholar 

  • World Health Organization (2011) TB/HIV Facts 2011–2012. http://www.who.int/tb/publications/TBHIV_Facts_for_2011.pdf

  • World Health Organization (2012a) Global tuberculosis report, 2012

    Google Scholar 

  • World Health Organization (2012b) Immunization summary: a statistical reference containing data through 2010

    Google Scholar 

  • World Health Organization (2012c) WHO prequalified vaccines. In: Immunization Standards. World Health Organization. http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/index.html

  • World Health Organization (2012d) WHO Technical Working Group on creation of an oral cholera vaccine stockpile. In: Diseases PaE (ed) Meeting report, 26–27 April 2012. WHO, Geneva

    Google Scholar 

  • Xu DQ, Zhang L, Kopecko DJ, Gao L, Shao Y, Guo B et al (2009) Bacterial delivery of siRNAs: a new approach to solid tumor therapy. Methods Mol Biol 487:161–187

    Google Scholar 

  • Yang XY, Chen QF, Li YP, Wu SM (2011) Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. PLoS ONE 6(9):e23826. doi:10.1371/journal.pone.0023826

    CAS  PubMed Central  PubMed  Google Scholar 

  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11(7):557–570. doi:10.1016/S1473-3099(11)70007-X

    PubMed  Google Scholar 

  • Zhang L, Prietsch SO, Axelsson I, Halperin SA (2011) Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 1:CD001478

    Google Scholar 

  • Zhang L, Prietsch SO, Axelsson I, Halperin SA (2012) Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 3:CD001478. doi:10.1002/14651858.CD001478.pub5

  • Zhou L, Pollard AJ (2010) A fast and highly sensitive blood culture PCR method for clinical detection of Salmonella enterica serovar Typhi. Ann Clin Microbiol Antimicrob 9:14

    PubMed Central  PubMed  Google Scholar 

  • Zorlu G (2012) Cholera vaccine deployed to control African outbreak. Nature 486(7402):157–286

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bacterial Vaccines—Discovery and Early Development, Crucell, Archimedesweg 4-6, 2333CN, Leiden, The Netherlands

    Anita H. J. van den Biggelaar & Jan T. Poolman

Authors
  1. Anita H. J. van den Biggelaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan T. Poolman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan T. Poolman .

Editor information

Editors and Affiliations

  1. Apex, North Carolina, USA

    Brian K. Nunnally

  2. Pfizer BioTherapeutics Pharmaceutical Sc, Pearl River, New York, USA

    Vincent E. Turula

  3. Sitrin Solutions, Lafayette Hill, Pennsylvania, USA

    Robert D. Sitrin

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

van den Biggelaar, A.H.J., Poolman, J.T. (2015). Live-Attenuated and Inactivated Whole-Cell Bacterial Vaccines. In: Nunnally, B., Turula, V., Sitrin, R. (eds) Vaccine Analysis: Strategies, Principles, and Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45024-6_5

Download citation

Publish with us

Policies and ethics

Search

Navigation